TLX — Telix Pharmaceuticals Ltd
Nasdaq ·
Materials ·
Chemicals ·
CIK 2007191 ·
Last close
$10.68
52W High
$18.49
52W Low
$6.28
ADV30
196,467
Last filing
SIC
2834
No quarterly fundamentals indexed for this ticker.
Balance + Analyst (yfinance extras)
Retained Earnings
$-154,538,000
Inventory
$37,080,000
Receivables
$138,371,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$803,793,984
EBITDA
$32,460,000
Free Cash Flow
$-36,673,500
Enterprise Value
$3,943,381,760
Total Cash
$141,866,000
Total Debt
$467,105,984
Shares Out
338,777,049
Trailing EPS
$-0.02
Book Value
$1.23
ROE
-1.9%
ROA
1.1%
Div Yield
—
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-05-06 21:32:08 | 2026-04-28 | Behrenbruch Christian | MD, Group CEO | P - Purchase | 14.67 | 67935 | 996738 |